View all trials
Are you a member? Sign in above to view additional information
  • Study title
    A phase 2 study of reduced therapy for newly diagnosed average-risk WNT-driven medulloblastoma patients
  • Protocol ID
    ACNS1422
  • Disease
    Disease Type Disease Subtype
  • Eligibility criteria
  • Study Status
    Open
  • Location(s)
    Women and Children's Hospital
    • Centre Study Status:
      Open
    • Notes:
  • Phase
    Phase 2
  • Study type
    Treatment
  • Diagnosis stage
    New diagnosis
  • Study open date
    N/A
  • Study close date
    N/A
  • Study chair
  • Sponsor
    Children's Oncology Group
Back to search results